1. Home
  2. FNLC vs TRDA Comparison

FNLC vs TRDA Comparison

Compare FNLC & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNLC
  • TRDA
  • Stock Information
  • Founded
  • FNLC 1864
  • TRDA 2016
  • Country
  • FNLC United States
  • TRDA United States
  • Employees
  • FNLC N/A
  • TRDA N/A
  • Industry
  • FNLC Major Banks
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNLC Finance
  • TRDA Health Care
  • Exchange
  • FNLC Nasdaq
  • TRDA Nasdaq
  • Market Cap
  • FNLC 303.4M
  • TRDA 264.4M
  • IPO Year
  • FNLC 1999
  • TRDA 2021
  • Fundamental
  • Price
  • FNLC $24.98
  • TRDA $6.74
  • Analyst Decision
  • FNLC
  • TRDA Strong Buy
  • Analyst Count
  • FNLC 0
  • TRDA 3
  • Target Price
  • FNLC N/A
  • TRDA $25.67
  • AVG Volume (30 Days)
  • FNLC 22.1K
  • TRDA 199.3K
  • Earning Date
  • FNLC 10-22-2025
  • TRDA 11-06-2025
  • Dividend Yield
  • FNLC 5.84%
  • TRDA N/A
  • EPS Growth
  • FNLC 18.07
  • TRDA N/A
  • EPS
  • FNLC 2.81
  • TRDA N/A
  • Revenue
  • FNLC $88,119,000.00
  • TRDA $79,476,000.00
  • Revenue This Year
  • FNLC N/A
  • TRDA N/A
  • Revenue Next Year
  • FNLC N/A
  • TRDA N/A
  • P/E Ratio
  • FNLC $8.85
  • TRDA N/A
  • Revenue Growth
  • FNLC 12.70
  • TRDA N/A
  • 52 Week Low
  • FNLC $22.11
  • TRDA $4.93
  • 52 Week High
  • FNLC $31.05
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • FNLC 46.53
  • TRDA 55.89
  • Support Level
  • FNLC $24.39
  • TRDA $6.35
  • Resistance Level
  • FNLC $25.46
  • TRDA $7.04
  • Average True Range (ATR)
  • FNLC 0.43
  • TRDA 0.45
  • MACD
  • FNLC 0.06
  • TRDA -0.01
  • Stochastic Oscillator
  • FNLC 40.13
  • TRDA 56.81

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: